Agendia BV (Agendia) has appointed Albert A. (Al) Luderer to its supervisory board. Luderer has over 30 years of experience in in vitro medical diagnostics, laboratory medicine and therapeutic development. Currently, he is the chief executive officer and president of BioTrove. Luderer is also the director of Light Micronics, Inc. and a scientific advisory board member at Washington University's Department of Biomedical Engineering, St. Louis, Missouri.
“We are very pleased to welcome Al to our Supervisory Board,” commented Bernhard Sixt, president and chief executive officer of Agendia. “As we continue to expand our U.S. activities, Al’s extensive experience and track record of success in the diagnostics industry will prove extremely valuable to Agendia’s growth.”
Previously, Luderer served as director, president and chief executive officer of Light Sciences Corporation where he spearheaded the company’s combined business, technical and commercial activities. Prior to joining Light Sciences Corporation, Luderer was president and chief operating officer at bioMerieux, Inc., a world leader in in vitro diagnostics. From 1987 – 1993, Luderer was at Boehringer Mannheim Corporation (now Roche) where he was named vice president of technology development and support. He started his work in the sector at Corning Inc. as a key figure negotiating the joint venture diagnostic company Ciba Corning (now Siemens Healthcare Diagnostics).
Luderer holds a Bachelor of Arts from Drew University and an M.S. and Ph.D. from Rutgers University where he was a National Science Foundation pre-doctoral fellow.